Q2 2021 Holdings
Filed 2021-08-16 | 23 holdings | $2.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc(COLL) | COM | 19459J104 | $2.4M | 100,000 | 98.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $5.2K | 75,000 | 0.2% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $4.0K | 100,000 | 0.2% |
| Pfizer Inc(PFE) | COM | 717081103 | $3.9K | 100,000 | 0.2% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $3.7K | 150,000 | 0.2% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $3.3K | 50,000 | 0.1% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $3.1K | 40,000 | 0.1% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $3.0K | 50,000 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $2.9K | 500,000 | 0.1% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $2.6K | 200,000 | 0.1% |
| Amryt Pharma PLC | SPONSORED ADS | 03217L106 | $2.4K | 200,000 | 0.1% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $2.2K | 500,000 | 0.1% |
| Tyme Technologies Inc | COM | 90238J103 | $1.9K | 1,500,000 | 0.1% |
| Vyne Therapeutics Inc(MNLOUSD) | COM | 92941V209 | $1.6K | 450,000 | 0.1% |
| Greenlane Hldgs Inc | CL A | 395330103 | $1.6K | 350,000 | 0.1% |
| Mimedx Group Inc(MDXG) | COM | 602496101 | $1.6K | 125,000 | 0.1% |
| Proshares TRCall | ULTRAPRO SHT QQQ | 74347G861 | $914 | 100,000 | 0.0% |
| Proshares TRCall | ULTRAPRO SHORT S | 74347B110 | $911 | 50,000 | 0.0% |
| Amarin Corp PLCCall | SPONS ADR NEW | 023111206 | $876 | 200,000 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD)Call | COM CL A | 46333X108 | $644 | 50,000 | 0.0% |
| Proshares TR IICall | VIX SH TRM FUTRS | 74347Y854 | $602 | 25,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $528 | 100,000 | 0.0% |
| Gamida Cell LTD | SHS | M47364100 | $481 | 75,000 | 0.0% |